FIELD: pharmacology.
SUBSTANCE: invention relates to compounds of formula and to pharmaceutical compositions based thereof.
EFFECT: new compounds are obtained with an affinity for the receptors to TAAR1 and can be used to treat depression, anxiety disorders, bipolar disorder, attention deficit/hyperactivity disorder, disorders caused by stress, psychotic disorders, schizophrenia, neurological diseases, Parkinson's disease, neurodegenerative disorders, Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse, metabolic disorders, malnutrition, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, temperature homeostasis disorders, sleep disturbance, circadian dysregulation and cardiovascular disorders.
23 cl, 16 dwg, 1 tbl, 55 ex
Title | Year | Author | Number |
---|---|---|---|
TRIAZOLCARBOXAMIDE DERIVATIVES | 2013 |
|
RU2637938C2 |
SUBSTITUTED BENZAMIDE DERIVATIVES | 2010 |
|
RU2595902C2 |
PIPERIDINYLPYRAZOLOPYRIMIDINONES AND USE THEREOF | 2015 |
|
RU2713937C2 |
2-OXA-5-AZABICYCLO[2.2.1]HEPTANE-3-YL DERIVATIVES | 2015 |
|
RU2697651C2 |
PHENOXYMETHYL DERIVATIVES | 2016 |
|
RU2746481C1 |
NOVEL PYRAZOLE PYRIMIDINE DERIVATIVES | 2017 |
|
RU2769448C2 |
MORPHOLINE-PYRIDINE DERIVATIVES | 2015 |
|
RU2690154C2 |
PIPERAZINO[1,2-A]INDOLE-1-ONES AND [1,4] DIAZEPTINO[1,2-A]INDOLE-1-ONE | 2014 |
|
RU2628126C2 |
PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES | 2015 |
|
RU2709810C2 |
Authors
Dates
2017-05-31—Published
2013-01-08—Filed